Repro-Med Systems Targets the Growing Home Infusion Therapy Market.

Business Editors/Health/Medical Writers

CHESTER, N.Y.--(BUSINESS WIRE)--March 5, 2004

Repro-Med (OTC BB: REPR) representatives have concluded the first showing of the Western U.S. Convention Circuit. After this promising event at the 13th Annual National Home Infusion Association's (NHIA) Convention at Caesars Palace in Las Vegas, Repro-Med representatives will head to Salt Lake City, this weekend for the EMS Today Conference.

In Las Vegas, Repro-Med met with a new distributor that looks to aggressively market Repro-Med products in the southeastern United States. With an emphasis on the Freedom 60 Syringe Infusion System, this will provide quality infusions to the patient at costs in the range of the current reimbursement. There was also great interest in the Res-Q-Vac(TM) Airway Suction System at the NHIA Convention. The patented hand-powered airway suction device is an essential tool for hospital, home, car and emergency use. In the home care environment, patients with swallowing disorders, tracheotomies or on ventilators need backup suction systems in the event of a power failure or simply to travel to the hospital. The Res-Q-Vac is ideal since it is portable, nonelectric and provides reliable performance in critical situations.

In conclusion of the NHIA Convention, Andy Sealfon, CEO of Repro-Med, enthusiastically said, "The NHIA may be one of the smaller Home Infusion Conventions, but it is certainly one of the best. Repro-Med was of great interest to many here as our Freedom 60 Syringe Infusion System and Res-Q-Vac(TM) are truly unique in this growing industry -- they save lives and money. Insurance reimbursement is constantly under pressure in the home infusion market, and our products provide an effective and cost-efficient solution."

The home infusion industry is one of the fastest-growing sectors of the medical industry. According to the NHIA Web site, annual revenues for home infusion therapies are estimated at approximately $4.5 billion. Revenue growth for the industry has averaged 10-12% in the past year. In 2004, future prospects for home infusion are even better.

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements can be identified by the lead-in "Looking Forward." These statements are not guarantees of future performance and involve significant risks and uncertainties. Actual results may vary materially from those in the forward-looking statements as a result of the effectiveness of management's strategies and decisions, general economic and business conditions, new or modified statutory or regulatory requirements, and changing price and market conditions. No assurance can be given that these are all the factors that could cause actual results to vary materially from the forward-looking statement.